Bilal Yousufzai, M.D.
Ophthalmology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Bilal Yousufzai, M.D. reported a CMS MIPS final score of 92.9/100 - above the 83.5 national average - and filed 387 Medicare Part D claims in 2023.
- 92.9/100
- MIPS score · +9 vs avg
- 387
- Part D claims, 2023
- 62%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1023458916 · Ophthalmology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1023458916
- ENUM-MID 2013
- TAX-MID 22K Ophthalmology Physician
- MIPS-ABOVE 92.9/100
- RX-LIGHT 387
- BOOK-THIN 86 in District of Columbia
- PHOTO-FINISH Ricardo Akstein · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Yousufzai · this…
Yousufzai · this provider
92.9 MIPS pts
- Amy Cherof · hig…
Amy Cherof
92.9 MIPS pts
- Ricardo Akstein …
Ricardo Akstein
92.9 MIPS pts
- Alan Benedict · …
Alan Benedict
92.9 MIPS pts
- Monica Bratton ·…
Monica Bratton
92.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Bilal Yousufzai, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
93 ≥ 66th percentile 66% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Bilal Yousufzai, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Bilal Yousufzai, M.D. writes more Part D claims than 21% of them and scores higher on MIPS quality than 61% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Bilal Yousufzai, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Bilal Yousufzai, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Bilal Yousufzai, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in District of Columbia
How Ophthalmology Physician compares to other specialties among District of Columbia providers
Ophthalmology Physician ranks #59 among District of Columbia's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the District of Columbia provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Bilal Yousufzai, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 92.9/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
92.9/100 MIPS final score - 9.4 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 80.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1023458916 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/25/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Bilal Yousufzai, M.D.'s current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1023458916 is the unique 10-digit identifier CMS uses to link Yousufzai across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Bilal Yousufzai, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Bilal Yousufzai, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$505
Largest payer
Harrow Eye, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
38% brand-name claims vs 62% generic, on 387 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 526
- Total Day Supply
- 14,568
- Brand vs Generic
- 38% brand / 62% generic
- Brand Drug Cost
- $15K
- Generic Drug Cost
- $11K
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.69
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Bilal Yousufzai, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
102 claims
- Latanoprost
Latanoprost
41 claims
- Dorzolamide Hcl 32
Dorzolamide Hcl
32 claims
- Ketorolac Trometha… 32
Ketorolac Tromethamine
32 claims
- Dorzolamide-Timolol 27
Dorzolamide-Timolol
27 claims
- Ciprofloxacin Hcl 18
Ciprofloxacin Hcl
18 claims
- Erythromycin 18
Erythromycin
18 claims
- Prolensa 14
Prolensa
14 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 102 |
| Latanoprost | 41 |
| Dorzolamide Hcl | 32 |
| Ketorolac Tromethamine | 32 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 |
| Ciprofloxacin Hcl | 18 |
| Erythromycin Erythromycin Base | 18 |
| Prolensa Bromfenac Sodium | 14 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 13 |
| Timolol Maleate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Bilal Yousufzai, M.D. fits within the Ophthalmology Physician landscape nationally.
Bilal Yousufzai, M.D.'s 387 claims are below the specialty average of 1,420.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Yousufzai, both outside District of Columbia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (92.9 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Yousufzai.
One of 86 Ophthalmology Physician providers enrolled in District of Columbia, 5 are shown here.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Bilal Yousufzai, M.D.'s specialty? ▼
How much does Bilal Yousufzai, M.D. prescribe under Medicare Part D? ▼
What is Bilal Yousufzai, M.D.'s Medicare quality score? ▼
Where is Bilal Yousufzai, M.D. located? ▼
What is Bilal Yousufzai, M.D.'s NPI number? ▼
Does Bilal Yousufzai, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Bilal Yousufzai, M.D. prescribe most often? ▼
Does Bilal Yousufzai, M.D. accept Medicare? ▼
How can I verify Bilal Yousufzai, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.